*Special Note regarding COVID-19

Important Update 9/16/20: Effective immediately, clients due to recertify in HDAP on September 30th and beyond will be subject to HDAP’s standard screening and enrollment procedures consistent with the ongoing phased reopening. All clients due to recertify in HDAP must submit a complete application that they are eligible for during this cycle (short or long form) with the required documentation. Clients who do not submit the appropriate application by their recertification date will term out of the program until their application is received and approved.

The following modifications to HDAP/CHII policies and procedures due to the COVID-19 public health emergency will remain in effect:

• For NEW clients applying to HDAP for the first time: 
  • Eligible clients who submit a long-form will be approved through HDAP’s standard screening/approval processes. 
  • If clients/case managers are unable to submit a complete application, CRI will accept a rapid eligibility form (see crine.org for downloadable form and guidance/instructions). Eligible clients will be approved for three months of HDAP coverage.
     
• HDAP/CHII will pay for health insurance premiums for all active and eligible CHII clients for insurance coverage through November 2020. 
• HDAP will reimburse pharmacies for prescription charges submitted for “early” fills (prescriptions filled before the usual refill approval date), as allowed by the client’s insurer.
• HDAP will reimburse pharmacies for prescription charges submitted for 60- or 90-day fills, as allowed by the client’s insurer.

Communicating with HDAP Staff 

• Please continue to contact HDAP through our main line at 617-502-1700. Please contact us via phone for any urgent client cases or clients with specific needs so that we may assist on a case-by-case basis.
• Applications, documentation, and forms can continue to be faxed to HDAP via our main fax line at 617-502-1703.
• To submit client applications, forms or information via email, please use our secure email system by:
  • Logging into our secure email portal here: https://web1.zixmail.net/s/login?b=crine. If you have never logged in before, you will be prompted to set up an account. Follow the instructions here for sending an email to HDAP: http://www.uapguide.com/community-research-initiative-of-new-englandhdap/customer/introduction, OR
  • Replying to a secure email sent from CRI. This will take you directly to our secure email portal.
• You may also reach us via email at HDAPleadership@crine.org with any questions or concerns.

Pre- Exposure Prophylaxix Drug Assistance Program (PrEPDAP)

To ensure that PrEPDAP clients do not experience a gap in coverage or access to medications or pre-exposure prophylaxis (PrEP) during this public health emergency, modifications such as extensions, early prescription refills and 60/90 day prescription refills are being made to PrEPDAP procedures and coverage, effective immediately. 

Please visit our PrEPDAP and COVID-19 Page to learn more.

We appreciate your patience as we work together to best serve the needs of our clients during this challenging time. 

Please be well and take care.